Amgen Inc. (AMGN)
$414.87+1.82%Close
BUYRECOVERY · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV13.5%–105.6%
- Market cap
- $223.9B
- Beta
- 0.41
- Div yield
- 2.47%
- P/E (TTM)
- 24.82
- IV-%ile
- 64
- IV ATM
- 30.2%
- Short % float
- 2.61%
- Days to cover
- 4.1
- SI change
- -0.3%
- 1W
- +2.94%
- 1M
- +8.47%
- vs SPY 1W
- +1.77%
- vs SPY 1M
- +5.48%
Industry peers
FMP comparable companies · ranked by market cap
- LLYBUYEli Lilly and Company$1.1TRECOVERYQ 21$1169.93+0.83%
- JNJSELLJohnson & Johnson$618.1BBEARQ 22$256.48+1.93%
- ABBVBUYAbbVie Inc.$481.3BBULLQ 29$272.42+1.49%
- MRKSELLMerck & Co., Inc.$351.7BBEARQ 11$142.40+2.26%
- RHHBYRoche Holding AG$340.1B$53.36
- NVSBUYNovartis AG$272.0BRECOVERYQ 20$143.11+0.45%
- AZNSELLAstraZeneca PLC$246.2BRECOVERYQ 20$158.78+0.26%
- PFESELLPfizer Inc.$158.6BBULLQ 13$27.82+1.65%
- BMYSELLBristol-Myers Squibb Company$121.7BBEARQ 10$59.58-0.77%
- GSKSELLGSK plc$93.2BRECOVERYQ 14$46.54-0.09%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on AMGN?
- LOPJLB’s latest quantitative signal on Amgen Inc. (AMGN) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is AMGN in?
- Amgen Inc. (AMGN) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Amgen Inc. (AMGN) do?
- Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematology, bone health, cardiovascular diseases, nephrol…